Share Price and Basic Stock Data
Last Updated: October 29, 2025, 5:14 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Gujarat Alkalies & Chemicals Ltd operates in the inorganic chemicals sector, primarily focusing on caustic soda and soda ash manufacturing. For the fiscal year ending March 2025, the company reported sales of ₹4,073 Cr, a decrease from ₹4,516 Cr in the previous year, reflecting a challenging market environment. The trailing twelve months (TTM) sales stood at ₹4,201 Cr, indicating a slight recovery from the previous fiscal’s downturn. Quarterly sales demonstrated volatility, with the most recent quarter (June 2024) recording ₹977 Cr, down from ₹1,138 Cr in March 2023. The operating profit margin (OPM) was notably low at 7% for FY 2025, down from 21% in FY 2023, indicating pressures on profitability likely due to rising input costs and competitive pricing pressures. The company’s expenses have consistently risen, culminating in ₹3,793 Cr for FY 2025, which poses challenges to maintaining margins amidst fluctuating demand and pricing in the chemicals sector.
Profitability and Efficiency Metrics
Gujarat Alkalies & Chemicals faced significant profitability challenges, reporting a net profit of -₹65 Cr for FY 2025, a stark decline from a profit of ₹410 Cr in FY 2023. This downturn is reflected in the earnings per share (EPS), which fell to -₹8.87 from ₹55.78 in the previous year. The operating profit for FY 2025 was reported at ₹279 Cr, which is a substantial drop from ₹949 Cr in FY 2023, contributing to an operating profit margin of just 7%. Efficiency ratios also reveal concerns; the return on equity (ROE) stood at a mere 1.13%, and the return on capital employed (ROCE) was low at 0.34%. The cash conversion cycle (CCC) remained relatively stable at 19 days, indicating efficient working capital management, but the overall profitability metrics signal a need for strategic adjustments to improve operational efficiency and cost management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Gujarat Alkalies & Chemicals reveals a stable capital structure with total borrowings of ₹561 Cr against reserves of ₹5,596 Cr, suggesting a manageable debt level. The current ratio stood at 1.13, indicating adequate liquidity to meet short-term obligations, although it has decreased from 1.68 in FY 2023. The interest coverage ratio (ICR) was healthy at 8.95, reflecting the company’s ability to cover interest expenses comfortably. However, the price-to-book value (P/BV) ratio at 0.75 indicates that the stock is trading at a discount compared to its book value, which may deter potential investors. The total liabilities stood at ₹7,987 Cr, down from ₹8,023 Cr in the previous fiscal year, indicating a slight reduction in leverage. Overall, while the balance sheet shows stability, the declining profitability and efficiency metrics pose risks to long-term financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Gujarat Alkalies & Chemicals reflects a diverse ownership structure, with promoters holding a steady 46.28% stake. Institutional investors, including Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs), held 1.02% and 4.52% respectively, indicating limited institutional interest. The public shareholding constituted a significant 48.16%, with a total of 70,371 shareholders as of March 2025, reflecting a broad base of retail investors. However, the decline in FII participation from 2.07% in December 2022 to 1.02% in June 2025 may signal waning confidence among foreign investors. Additionally, the fluctuating public shareholding percentage indicates potential volatility in investor sentiment, particularly in response to the company’s recent financial performance. The stability of promoter holdings suggests a commitment to the company’s long-term strategy, yet the overall investor confidence may be tempered by the recent financial results.
Outlook, Risks, and Final Insight
The outlook for Gujarat Alkalies & Chemicals hinges on its ability to navigate current market challenges and improve its profitability metrics. The significant decline in net profit and EPS raises concerns about sustainability, particularly in a competitive chemicals market. Key risks include rising raw material costs and a potential slowdown in demand for caustic soda and soda ash, which could further pressure margins. On the other hand, the company’s strong balance sheet and manageable debt levels provide a buffer against economic uncertainties. Strategic initiatives focused on cost optimization and operational efficiencies may enhance profitability in the medium term. If the company can stabilize its earnings and regain investor confidence, it may attract increased institutional interest and improve its market valuation. Conversely, continued financial underperformance could lead to further declines in share price and investor sentiment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Gujarat Alkalies & Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Caprolactam Chemicals Ltd | 20.2 Cr. | 43.8 | 65.0/37.5 | 10.5 | 0.00 % | 0.48 % | 13.7 % | 10.0 | |
| Standard Industries Ltd | 121 Cr. | 18.7 | 31.1/17.4 | 18.6 | 0.00 % | 7.81 % | 10.5 % | 5.00 | |
| Gujarat Alkalies & Chemicals Ltd | 4,102 Cr. | 559 | 894/484 | 772 | 2.83 % | 0.34 % | 1.13 % | 10.0 | |
| GHCL Ltd | 6,126 Cr. | 638 | 779/511 | 9.92 | 364 | 1.88 % | 24.2 % | 18.6 % | 10.0 |
| Tata Chemicals Ltd | 23,026 Cr. | 904 | 1,165/756 | 54.6 | 847 | 1.22 % | 3.96 % | 1.20 % | 10.0 |
| Industry Average | 6,849.20 Cr | 461.58 | 39.34 | 382.68 | 1.02% | 7.11% | 8.14% | 9.17 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,128 | 1,127 | 1,123 | 1,138 | 913 | 971 | 921 | 1,002 | 977 | 991 | 1,029 | 1,075 | 1,105 |
| Expenses | 778 | 969 | 885 | 936 | 882 | 955 | 941 | 998 | 923 | 945 | 951 | 974 | 1,010 |
| Operating Profit | 351 | 159 | 238 | 202 | 31 | 16 | -20 | 4 | 54 | 46 | 78 | 101 | 95 |
| OPM % | 31% | 14% | 21% | 18% | 3% | 2% | -2% | 0% | 6% | 5% | 8% | 9% | 9% |
| Other Income | 6 | 22 | 6 | 8 | 12 | 71 | 5 | 3 | 3 | 49 | 15 | 24 | 8 |
| Interest | 2 | 3 | 8 | 8 | 10 | 11 | 11 | 12 | 11 | 11 | 10 | 18 | 14 |
| Depreciation | 50 | 60 | 79 | 88 | 89 | 95 | 96 | 97 | 97 | 100 | 98 | 97 | 102 |
| Profit before tax | 305 | 118 | 157 | 115 | -57 | -18 | -123 | -102 | -50 | -16 | -15 | 10 | -12 |
| Tax % | 37% | 49% | 44% | 38% | 0% | -0% | -6% | -55% | -11% | 15% | -27% | 13% | 15% |
| Net Profit | 191 | 61 | 87 | 71 | -57 | -18 | -115 | -46 | -45 | -18 | -11 | 9 | -14 |
| EPS in Rs | 25.99 | 8.24 | 11.87 | 9.67 | -7.78 | -2.50 | -15.68 | -6.29 | -6.06 | -2.48 | -1.53 | 1.20 | -1.88 |
Last Updated: August 20, 2025, 10:00 am
Below is a detailed analysis of the quarterly data for Gujarat Alkalies & Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,105.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,075.00 Cr. (Mar 2025) to 1,105.00 Cr., marking an increase of 30.00 Cr..
- For Expenses, as of Jun 2025, the value is 1,010.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 974.00 Cr. (Mar 2025) to 1,010.00 Cr., marking an increase of 36.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 95.00 Cr.. The value appears to be declining and may need further review. It has decreased from 101.00 Cr. (Mar 2025) to 95.00 Cr., marking a decrease of 6.00 Cr..
- For OPM %, as of Jun 2025, the value is 9.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00%.
- For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 16.00 Cr..
- For Interest, as of Jun 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 18.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 4.00 Cr..
- For Depreciation, as of Jun 2025, the value is 102.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 97.00 Cr. (Mar 2025) to 102.00 Cr., marking an increase of 5.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2025) to -12.00 Cr., marking a decrease of 22.00 Cr..
- For Tax %, as of Jun 2025, the value is 15.00%. The value appears to be increasing, which may not be favorable. It has increased from 13.00% (Mar 2025) to 15.00%, marking an increase of 2.00%.
- For Net Profit, as of Jun 2025, the value is -14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to -14.00 Cr., marking a decrease of 23.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -1.88. The value appears to be declining and may need further review. It has decreased from 1.20 (Mar 2025) to -1.88, marking a decrease of 3.08.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:15 am
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,995 | 2,070 | 2,455 | 3,161 | 2,725 | 2,429 | 3,759 | 4,516 | 3,807 | 4,073 | 4,201 |
| Expenses | 1,660 | 1,622 | 1,669 | 2,046 | 2,148 | 2,072 | 2,774 | 3,568 | 3,775 | 3,793 | 3,880 |
| Operating Profit | 335 | 448 | 786 | 1,115 | 577 | 357 | 984 | 949 | 32 | 279 | 321 |
| OPM % | 17% | 22% | 32% | 35% | 21% | 15% | 26% | 21% | 1% | 7% | 8% |
| Other Income | 45 | 56 | 106 | 62 | 90 | 67 | 46 | 42 | 90 | 92 | 97 |
| Interest | 10 | 13 | 15 | 21 | 14 | 15 | 6 | 19 | 45 | 51 | 53 |
| Depreciation | 107 | 111 | 127 | 140 | 162 | 174 | 198 | 276 | 377 | 392 | 398 |
| Profit before tax | 262 | 381 | 749 | 1,016 | 491 | 235 | 826 | 695 | -300 | -71 | -33 |
| Tax % | 16% | 19% | 29% | 32% | 32% | 29% | 32% | 41% | -21% | -9% | |
| Net Profit | 220 | 307 | 534 | 690 | 332 | 166 | 560 | 410 | -237 | -65 | -34 |
| EPS in Rs | 29.90 | 41.85 | 72.78 | 93.98 | 45.22 | 22.57 | 76.22 | 55.78 | -32.25 | -8.87 | -4.69 |
| Dividend Payout % | 15% | 12% | 9% | 9% | 18% | 35% | 13% | 42% | -43% | -178% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 39.55% | 73.94% | 29.21% | -51.88% | -50.00% | 237.35% | -26.79% | -157.80% | 72.57% |
| Change in YoY Net Profit Growth (%) | 0.00% | 34.40% | -44.73% | -81.10% | 1.88% | 287.35% | -264.14% | -131.02% | 230.38% |
Gujarat Alkalies & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 3% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 85% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 11% |
| 3 Years: | -15% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 1% |
| Last Year: | -1% |
Last Updated: September 5, 2025, 5:30 am
Balance Sheet
Last Updated: June 16, 2025, 12:03 pm
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 |
| Reserves | 2,854 | 3,282 | 3,748 | 4,222 | 4,522 | 5,301 | 5,826 | 6,066 | 6,002 | 5,596 |
| Borrowings | 295 | 353 | 291 | 247 | 205 | 498 | 594 | 597 | 544 | 561 |
| Other Liabilities | 671 | 726 | 859 | 988 | 1,090 | 1,282 | 1,484 | 1,599 | 1,404 | 1,756 |
| Total Liabilities | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 7,987 |
| Fixed Assets | 1,821 | 2,073 | 2,104 | 2,300 | 2,610 | 2,587 | 2,702 | 4,250 | 4,617 | 4,584 |
| CWIP | 83 | 151 | 252 | 307 | 445 | 1,109 | 1,787 | 544 | 95 | 79 |
| Investments | 854 | 1,016 | 1,145 | 1,065 | 1,242 | 2,092 | 2,110 | 1,831 | 2,093 | 1,976 |
| Other Assets | 1,136 | 1,196 | 1,469 | 1,858 | 1,594 | 1,366 | 1,379 | 1,710 | 1,218 | 1,348 |
| Total Assets | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 7,987 |
Below is a detailed analysis of the balance sheet data for Gujarat Alkalies & Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 73.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 73.00 Cr..
- For Reserves, as of Mar 2025, the value is 5,596.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,002.00 Cr. (Mar 2024) to 5,596.00 Cr., marking a decrease of 406.00 Cr..
- For Borrowings, as of Mar 2025, the value is 561.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 544.00 Cr. (Mar 2024) to 561.00 Cr., marking an increase of 17.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1,756.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,404.00 Cr. (Mar 2024) to 1,756.00 Cr., marking an increase of 352.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 7,987.00 Cr.. The value appears to be improving (decreasing). It has decreased from 8,023.00 Cr. (Mar 2024) to 7,987.00 Cr., marking a decrease of 36.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 4,584.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,617.00 Cr. (Mar 2024) to 4,584.00 Cr., marking a decrease of 33.00 Cr..
- For CWIP, as of Mar 2025, the value is 79.00 Cr.. The value appears to be declining and may need further review. It has decreased from 95.00 Cr. (Mar 2024) to 79.00 Cr., marking a decrease of 16.00 Cr..
- For Investments, as of Mar 2025, the value is 1,976.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,093.00 Cr. (Mar 2024) to 1,976.00 Cr., marking a decrease of 117.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,348.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,218.00 Cr. (Mar 2024) to 1,348.00 Cr., marking an increase of 130.00 Cr..
- For Total Assets, as of Mar 2025, the value is 7,987.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8,023.00 Cr. (Mar 2024) to 7,987.00 Cr., marking a decrease of 36.00 Cr..
Notably, the Reserves (5,596.00 Cr.) exceed the Borrowings (561.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 40.00 | 95.00 | 495.00 | -246.00 | 372.00 | -141.00 | 390.00 | 352.00 | -512.00 | -282.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 58 | 60 | 56 | 50 | 43 | 29 | 23 | 17 | 24 |
| Inventory Days | 99 | 94 | 147 | 99 | 92 | 88 | 101 | 111 | 93 | 110 |
| Days Payable | 99 | 125 | 154 | 134 | 126 | 111 | 101 | 119 | 86 | 115 |
| Cash Conversion Cycle | 60 | 27 | 53 | 22 | 17 | 21 | 29 | 15 | 25 | 19 |
| Working Capital Days | 89 | 81 | 98 | 96 | 107 | 10 | 4 | 5 | -1 | -3 |
| ROCE % | 11% | 18% | 24% | 11% | 5% | 13% | 11% | -4% | -0% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Regular Savings Fund | 75,047 | 0.18 | 5.96 | 75,047 | 2025-04-22 17:25:34 | 0% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 31,263 | 0.18 | 2.48 | 31,263 | 2025-04-22 17:25:34 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -8.87 | -32.25 | 55.78 | 76.22 | 22.57 |
| Diluted EPS (Rs.) | -8.87 | -32.25 | 55.78 | 76.22 | 22.57 |
| Cash EPS (Rs.) | 55.57 | 33.38 | 115.99 | 103.46 | 46.46 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 772.02 | 827.30 | 835.97 | 803.30 | 731.86 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 772.02 | 827.30 | 835.97 | 803.30 | 731.86 |
| Revenue From Operations / Share (Rs.) | 554.60 | 518.34 | 615.01 | 511.82 | 330.82 |
| PBDIT / Share (Rs.) | 61.62 | 30.79 | 157.51 | 140.60 | 57.96 |
| PBIT / Share (Rs.) | 8.21 | -20.60 | 119.92 | 113.67 | 34.21 |
| PBT / Share (Rs.) | 1.32 | -26.67 | 117.27 | 112.83 | 32.11 |
| Net Profit / Share (Rs.) | 2.15 | -18.01 | 78.39 | 76.52 | 22.72 |
| NP After MI And SOA / Share (Rs.) | -8.87 | -32.25 | 55.78 | 76.22 | 22.57 |
| PBDIT Margin (%) | 11.11 | 5.93 | 25.61 | 27.47 | 17.51 |
| PBIT Margin (%) | 1.47 | -3.97 | 19.49 | 22.20 | 10.34 |
| PBT Margin (%) | 0.23 | -5.14 | 19.06 | 22.04 | 9.70 |
| Net Profit Margin (%) | 0.38 | -3.47 | 12.74 | 14.95 | 6.86 |
| NP After MI And SOA Margin (%) | -1.59 | -6.22 | 9.06 | 14.89 | 6.82 |
| Return on Networth / Equity (%) | -1.14 | -3.89 | 6.67 | 9.48 | 3.08 |
| Return on Capital Employeed (%) | 0.85 | -2.07 | 11.75 | 11.52 | 3.84 |
| Return On Assets (%) | -0.81 | -2.95 | 4.91 | 7.01 | 2.31 |
| Long Term Debt / Equity (X) | 0.05 | 0.05 | 0.07 | 0.09 | 0.08 |
| Total Debt / Equity (X) | 0.09 | 0.08 | 0.09 | 0.10 | 0.08 |
| Asset Turnover Ratio (%) | 0.50 | 0.46 | 0.55 | 0.49 | 0.37 |
| Current Ratio (X) | 1.13 | 1.23 | 1.68 | 1.49 | 1.78 |
| Quick Ratio (X) | 0.60 | 0.67 | 1.13 | 1.01 | 1.41 |
| Inventory Turnover Ratio (X) | 9.12 | 6.75 | 6.45 | 6.97 | 6.16 |
| Dividend Payout Ratio (NP) (%) | -156.19 | -73.02 | 17.92 | 10.49 | 35.44 |
| Dividend Payout Ratio (CP) (%) | 31.08 | 123.03 | 10.70 | 7.75 | 17.27 |
| Earning Retention Ratio (%) | 256.19 | 173.02 | 82.08 | 89.51 | 64.56 |
| Cash Earning Retention Ratio (%) | 68.92 | -23.03 | 89.30 | 92.25 | 82.73 |
| Interest Coverage Ratio (X) | 8.95 | 5.07 | 59.43 | 168.00 | 27.53 |
| Interest Coverage Ratio (Post Tax) (X) | 1.31 | -1.97 | 30.58 | 92.43 | 11.79 |
| Enterprise Value (Cr.) | 4670.05 | 5324.43 | 4435.11 | 6873.06 | 2607.27 |
| EV / Net Operating Revenue (X) | 1.15 | 1.40 | 0.98 | 1.83 | 1.07 |
| EV / EBITDA (X) | 10.32 | 23.55 | 3.83 | 6.66 | 6.13 |
| MarketCap / Net Operating Revenue (X) | 1.04 | 1.30 | 0.95 | 1.75 | 1.04 |
| Retention Ratios (%) | 256.19 | 173.02 | 82.07 | 89.50 | 64.55 |
| Price / BV (X) | 0.75 | 0.81 | 0.70 | 1.12 | 0.47 |
| Price / Net Operating Revenue (X) | 1.04 | 1.30 | 0.95 | 1.75 | 1.04 |
| EarningsYield | -0.01 | -0.04 | 0.09 | 0.08 | 0.06 |
After reviewing the key financial ratios for Gujarat Alkalies & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -8.87. This value is below the healthy minimum of 5. It has increased from -32.25 (Mar 24) to -8.87, marking an increase of 23.38.
- For Diluted EPS (Rs.), as of Mar 25, the value is -8.87. This value is below the healthy minimum of 5. It has increased from -32.25 (Mar 24) to -8.87, marking an increase of 23.38.
- For Cash EPS (Rs.), as of Mar 25, the value is 55.57. This value is within the healthy range. It has increased from 33.38 (Mar 24) to 55.57, marking an increase of 22.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 772.02. It has decreased from 827.30 (Mar 24) to 772.02, marking a decrease of 55.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 772.02. It has decreased from 827.30 (Mar 24) to 772.02, marking a decrease of 55.28.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 554.60. It has increased from 518.34 (Mar 24) to 554.60, marking an increase of 36.26.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 61.62. This value is within the healthy range. It has increased from 30.79 (Mar 24) to 61.62, marking an increase of 30.83.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.21. This value is within the healthy range. It has increased from -20.60 (Mar 24) to 8.21, marking an increase of 28.81.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.32. This value is within the healthy range. It has increased from -26.67 (Mar 24) to 1.32, marking an increase of 27.99.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.15. This value is within the healthy range. It has increased from -18.01 (Mar 24) to 2.15, marking an increase of 20.16.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -8.87. This value is below the healthy minimum of 2. It has increased from -32.25 (Mar 24) to -8.87, marking an increase of 23.38.
- For PBDIT Margin (%), as of Mar 25, the value is 11.11. This value is within the healthy range. It has increased from 5.93 (Mar 24) to 11.11, marking an increase of 5.18.
- For PBIT Margin (%), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 10. It has increased from -3.97 (Mar 24) to 1.47, marking an increase of 5.44.
- For PBT Margin (%), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 10. It has increased from -5.14 (Mar 24) to 0.23, marking an increase of 5.37.
- For Net Profit Margin (%), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 5. It has increased from -3.47 (Mar 24) to 0.38, marking an increase of 3.85.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -1.59. This value is below the healthy minimum of 8. It has increased from -6.22 (Mar 24) to -1.59, marking an increase of 4.63.
- For Return on Networth / Equity (%), as of Mar 25, the value is -1.14. This value is below the healthy minimum of 15. It has increased from -3.89 (Mar 24) to -1.14, marking an increase of 2.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 10. It has increased from -2.07 (Mar 24) to 0.85, marking an increase of 2.92.
- For Return On Assets (%), as of Mar 25, the value is -0.81. This value is below the healthy minimum of 5. It has increased from -2.95 (Mar 24) to -0.81, marking an increase of 2.14.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. It has increased from 0.08 (Mar 24) to 0.09, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.50. It has increased from 0.46 (Mar 24) to 0.50, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.13. This value is below the healthy minimum of 1.5. It has decreased from 1.23 (Mar 24) to 1.13, marking a decrease of 0.10.
- For Quick Ratio (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.60, marking a decrease of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.12. This value exceeds the healthy maximum of 8. It has increased from 6.75 (Mar 24) to 9.12, marking an increase of 2.37.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -156.19. This value is below the healthy minimum of 20. It has decreased from -73.02 (Mar 24) to -156.19, marking a decrease of 83.17.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 31.08. This value is within the healthy range. It has decreased from 123.03 (Mar 24) to 31.08, marking a decrease of 91.95.
- For Earning Retention Ratio (%), as of Mar 25, the value is 256.19. This value exceeds the healthy maximum of 70. It has increased from 173.02 (Mar 24) to 256.19, marking an increase of 83.17.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 68.92. This value is within the healthy range. It has increased from -23.03 (Mar 24) to 68.92, marking an increase of 91.95.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.95. This value is within the healthy range. It has increased from 5.07 (Mar 24) to 8.95, marking an increase of 3.88.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 3. It has increased from -1.97 (Mar 24) to 1.31, marking an increase of 3.28.
- For Enterprise Value (Cr.), as of Mar 25, the value is 4,670.05. It has decreased from 5,324.43 (Mar 24) to 4,670.05, marking a decrease of 654.38.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.15, marking a decrease of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 10.32. This value is within the healthy range. It has decreased from 23.55 (Mar 24) to 10.32, marking a decrease of 13.23.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.30 (Mar 24) to 1.04, marking a decrease of 0.26.
- For Retention Ratios (%), as of Mar 25, the value is 256.19. This value exceeds the healthy maximum of 70. It has increased from 173.02 (Mar 24) to 256.19, marking an increase of 83.17.
- For Price / BV (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has decreased from 0.81 (Mar 24) to 0.75, marking a decrease of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.30 (Mar 24) to 1.04, marking a decrease of 0.26.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has increased from -0.04 (Mar 24) to -0.01, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Alkalies & Chemicals Ltd:
- Net Profit Margin: 0.38%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.85% (Industry Average ROCE: 7.11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -1.14% (Industry Average ROE: 8.14%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.6
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 19.67)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.09
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.38%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Caustic Soda/Soda Ash | P.O.: Ranoli, Vadodra District Gujarat 391350 | investor_relations@gacl.co.in http://www.gacl.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Hasmukh Adhia | Chairman |
| Ms. Avantika Singh Aulakh | Managing Director |
| Mr. Rajiv Lochan Jain | Independent Director |
| Mr. Nitin Shukla | Independent Director |
| Mr. Shridevi Shukla | Independent Director |
| Mr. Bimal Julka | Independent Director |
| Dr. Chinmay Ghoroi | Independent Director |
| Mr. S J Haider | Director |
| Dr. T Natarajan | Director |
FAQ
What is the intrinsic value of Gujarat Alkalies & Chemicals Ltd?
Gujarat Alkalies & Chemicals Ltd's intrinsic value (as of 29 October 2025) is 107.65 which is 80.74% lower the current market price of 559.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,102 Cr. market cap, FY2025-2026 high/low of 894/484, reserves of ₹5,596 Cr, and liabilities of 7,987 Cr.
What is the Market Cap of Gujarat Alkalies & Chemicals Ltd?
The Market Cap of Gujarat Alkalies & Chemicals Ltd is 4,102 Cr..
What is the current Stock Price of Gujarat Alkalies & Chemicals Ltd as on 29 October 2025?
The current stock price of Gujarat Alkalies & Chemicals Ltd as on 29 October 2025 is 559.
What is the High / Low of Gujarat Alkalies & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gujarat Alkalies & Chemicals Ltd stocks is 894/484.
What is the Stock P/E of Gujarat Alkalies & Chemicals Ltd?
The Stock P/E of Gujarat Alkalies & Chemicals Ltd is .
What is the Book Value of Gujarat Alkalies & Chemicals Ltd?
The Book Value of Gujarat Alkalies & Chemicals Ltd is 772.
What is the Dividend Yield of Gujarat Alkalies & Chemicals Ltd?
The Dividend Yield of Gujarat Alkalies & Chemicals Ltd is 2.83 %.
What is the ROCE of Gujarat Alkalies & Chemicals Ltd?
The ROCE of Gujarat Alkalies & Chemicals Ltd is 0.34 %.
What is the ROE of Gujarat Alkalies & Chemicals Ltd?
The ROE of Gujarat Alkalies & Chemicals Ltd is 1.13 %.
What is the Face Value of Gujarat Alkalies & Chemicals Ltd?
The Face Value of Gujarat Alkalies & Chemicals Ltd is 10.0.